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Abstract
Background: In the last years more and more multi-omics data are becoming available, that is, data featuring
measurements of several types of omics data for each patient. Using multi-omics data as covariate data in outcome
prediction is both promising and challenging due to the complex structure of such data. Random forest is a
prediction method known for its ability to render complex dependency patterns between the outcome and the
covariates. Against this background we developed five candidate random forest variants tailored to multi-omics
covariate data. These variants modify the split point selection of random forest to incorporate the block structure of
multi-omics data and can be applied to any outcome type for which a random forest variant exists, such as
categorical, continuous and survival outcomes. Using 20 publicly available multi-omics data sets with survival
outcome we compared the prediction performances of the block forest variants with alternatives. We also considered
the common special case of having clinical covariates and measurements of a single omics data type available.
Results: We identify one variant termed “block forest” that outperformed all other approaches in the comparison
study. In particular, it performed significantly better than standard random survival forest (adjusted p-value: 0.027). The
two best performing variants have in common that the block choice is randomized in the split point selection
procedure. In the case of having clinical covariates and a single omics data type available, the improvements of the
variants over random survival forest were larger than in the case of the multi-omics data. The degrees of
improvements over random survival forest varied strongly across data sets. Moreover, considering all clinical
covariates mandatorily improved the performance. This result should however be interpreted with caution, because
the level of predictive information contained in clinical covariates depends on the specific application.
Conclusions: The new prediction method block forest for multi-omics data can significantly improve the prediction
performance of random forest and outperformed alternatives in the comparison. Block forest is particularly effective
for the special case of using clinical covariates in combination with measurements of a single omics data type.
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Background
In the last decade the measurement of various types
of omics data, such as gene expression, methylation or
copy number variation data has become increasingly fast
and cost-effective. Therefore, there exist more and more
patient data for which several types of omics data are
available for the same patients. In the following, such
data are denoted as multi-omics data and the different
subsets of this data containing the individual data types
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are referred to as “blocks”. Using multi-omics data in
prediction modeling is promising because each type of
omics data may contribute information valuable for the
prediction of phenotypic outcomes. However, combin-
ing different types of omics data effectively is challenging
for several reasons. First, the predictive information con-
tained in the individual blocks is overlapping. Second,
the levels of predictive information differ between the
blocks and depend on the particular outcome consid-
ered [1]. Third, there exist interactions between variables
across the different blocks, which should be taken into
account [2].
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While pioneering work in the area of prediction mod-
elling using multi-omics covariate data was already
published as early as 2004 [3], further methodological
developments in this area rarely seem to have been pur-
sued until the last several years. A PubMed search for
the term “multi-omics” resulted in two papers from the
year 2006 (first mentioning of the term), five papers from
the year 2010, but 368 papers from the year 2018. This
long-lasting lack of prediction methods tailored to multi-
omics covariate data was probably due to the fact that
multi-omics data had not been available on a larger scale
until recently. Simon et al. [4] presented the sparse group
lasso in 2013, a prediction method for grouped covariate
data that automatically removes non-informative covari-
ate groups and performs lasso-type variable selection for
the remaining covariate groups. A disadvantage of the
sparse lasso in applications to multi-omics data is that it
does not explicitly take the different levels of predictive
information of the blocks into account. This is different
for the IPF-LASSO [5], a lasso-type regression method
for multi-omics data in which each block is associated
with an individual penalty parameter. Vazquez et al. [6]
model the relationship between phenotypic outcomes and
multi-omics covariate data fully Bayesian using a Bayesian
generalized additive model. Mankoo et al. [7] consider a
two-step approach: In the first step they aim to remove
redundancies between the different blocks by filtering out
highly correlated pairs of variables from different blocks
and in the second step they apply standard L1 regularized
Cox regression [8] using the remaining variables. Seoane
et al. [9] use multiple kernel learning methods, consid-
ering composite kernels as linear combinations of base
kernels derived from each block, where they incorporate
pathway information in the selection of relevant variables.
Similarly, Fuchs et al. [10] consider combining classifiers,
each learned using one of the blocks. In the context of
a comparison study, Boulesteix et al. [5] again consider
an approach based on combining prediction rules, each
learned using a single block: first, lasso is fitted to each
block and, second, the resulting linear predictors are used
as covariates in a low-dimensional regression model. In
addition to the approach mentioned above, Fuchs et al.
[10] also consider performing variable selection separately
for each block and then learning a single classifier using
all blocks. Klau et al. [11] present the priority-Lasso, a
lasso-type prediction method for multi-omics data that
differs from the approaches described above in that its
main focus is not prediction accuracy but applicability
from a practical point of view: with this method the user
has to provide a priority order of the blocks that is for
example motivated by the costs of generating each type
of data. Blocks of low priority are likely to be automat-
ically excluded by this method, which should frequently
lead to prediction rules that are easy to apply in practice
and, at the same time, feature a high prediction accuracy.
A related method is the TANDEM approach [12], which
attributes a lower priority to gene expressions than to the
other omics data types in order to avoid the prediction
rule to be strongly dominated by the gene expressions. For
a recent overview of approaches for analyzingmulti-omics
data focused on data mining see Huang et al. [2]. Recently,
a multi-omics deep learning approach, SALMON [13],
was suggested that employs eigengenes in neural networks
to learn hidden layers, which are subsequently used in Cox
regression. A supervised dimension reduction method for
multi-omics data called Integrative SIR (ISIR) was also
proposed recently [14]. Beyond conventional prediction
modelling, the integrative analysis of different omics data
types can deliver new insights into biomedical processes;
see, for example, Yaneske & Angione [15] for a multi-
omics based assessment procedure of biological age of
humans. An extensive review of various statistical pro-
cedures commonly used in practice in the analysis of
multi-omics data can be found in Wu et al. [16].
Apart from multi-omics data, in most cases where a
certain type of omics data is available, the correspond-
ing phenotypic data set features several clinical covariates.
The latter are often of great prognostic relevance and
should be prioritized over or at least be used in addition to
the omics data. Many of the methods described above can
be used for such data as well, if the clinical data is treated
as an omics data type from amethodological point of view.
However, since this problem was known before the rise
of multi-omics data, there also exist various strategies for
effectively using the clinical information in combination
with a single omics data type. See Boulesteix & Sauer-
brei [17] for a detailed discussion of such approaches and
De Bin et al. [18] for a comparison study illustrating their
application.
The random forest algorithm [19] is a powerful pre-
diction method that is known to be able to capture
complex dependency patterns between the outcome and
the covariates. The latter feature makes random forest a
promising candidate for developing a prediction method
tailored to the challenges of multi-omics data. In this
paper we set out to develop such a variant, where we ini-
tially consider five different candidate methods. Each of
these five considered random forest variants differs from
conventional random forests merely with respect to the
selection of the split points in the decision trees consti-
tuting the forests. Therefore, most other components of a
random forest are unchanged and each of these five vari-
ants can be applied to any outcome type, for which there
exists a random forest variant, e.g., categorial, continuous
and survival outcomes. Using 20 real multi-omics data
sets with survival outcome we compared the prediction
performances of the five variants with each other and
with alternatives, including random survival forest (RSF)
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[20] as a reference method. RSF is known to be a strong
prediction method for survival outcomes, see for example
Bou-Hamad et al. [21] and Yosefian et al. [22] and the
references therein. In this comparison study we identified
one particularly well performing variant that performed
best, both when considering all blocks and for the special
case of having only clinical information and a single omics
data type. This variant is denoted as the block forest
algorithm in the following. We implemented all five vari-
ants for categorical, continuous and survival outcomes
in our R package blockForest (version 0.2.0) avail-
able from CRAN (https://cran.r-project.org/package=
blockForest, GitHub version: https://github.com/bips-
hb/blockForest), where block forest is used by default.
The other variants should be considered with caution
only as these may deliver worse prediction results. In an
additional analysis, we considered variations of the five
variants that include all clinical covariates mandatorily in
the split point selection (see “Outlook: Prioritizing the
clinical covariates by including them mandatorily
in the split point selection” subsection of “Results”
section).
We present all five considered variants in the paper and
the results obtained for these. As noted above, we recom-
mend the variant that performed best in the comparison
for use in practice. Merely reporting the results obtained
with the variant that performed best would have been
associated with overoptimism, similar to that associated
with reporting only significant results after performing
several statistical tests.
The paper is structured as follows. In the next section,
the results of the comparison study are presented and
described. In “Discussion” section, we summarize our
main results and draw specific conclusions from the
results of the comparison study. The main conclusions
are summarized in “Conclusions” section. Finally, in
“Methods” section, after briefly describing the multi-
omics data format and the splitting procedure performed
by standard random forest, we detail each of the five
considered random forest variants for multi-omics data.
Here, we also discuss the rationale behind each proce-
dure. Lastly, we describe the design of the comparison
study.
Results
In the following, we will present and evaluate the results of
our comparison study. As noted above, detailed descrip-
tions of the design of the comparison study and the
five considered variants are given in “Methods” section.
The five variants are denoted as VarProb, SplitWeights,
BlockVarSel, RandomBlock, and BlockForest. Consulting
“Methods” section before reading the current section fur-
ther should make it easier to follow the results presented
in the following.
Multi-omics data
Figure 1 shows the results of the multi-omics compari-
son study. Figure 1a shows boxplots of the mean cross-
validated C index values obtained for all methods and
data sets, Fig. 1b shows the differences between the mean
cross-validated C index values obtained for the different
methods and those obtained using RSF, and Fig. 1c shows
boxplots of ranks of the methods calculated using the
mean cross-validated C index values of the data sets. On
average, BlockForest and RandomBlock performed best
among all methods. Specifically, BlockForest achieved
the highest median C index across the data sets and a
median rank of 2.5. The mean ranks of the methods
are as follows (from best to worst): 2.95 (BlockForest),
3.55 (RandomBlock), 5.45 (RSF), 5.45 (IPF-LASSO), 5.6
(Boost), 5.85 (BlockVarSel), 6.1 (VarProb), 6.45 (Lasso),
6.55 (SplitWeights), 7.05 (priority-Lasso). The ranks of
IPF-LASSO are very variable across data sets. For some
data sets it performed best, but mediocre to bad for
the majority of data sets. By contrast, priority-Lasso per-
formed worst in this comparison, slightly worse than the
original Lasso. RSF performed best among the meth-
ods that do not take the block structure into account,
followed by boosting and Lasso. In Additional file 1:
Figures S1 and S2 the C index values obtained for the
individual repetitions of the cross-validation are shown
separately for each data set. Note that, for three of the
20 data sets, only four of the five considered blocks
were available. Because the results might be systemat-
ically different for these three data sets, as a sensitiv-
ity analysis we temporarily excluded these three data
sets and re-produced Fig. 1. The results are shown
in Additional file 1: Figure S3. While the results are
not drastically different under the exclusion of these
three data sets, we observe that the improvements of
BlockForest and RandomBlock over RSF became slightly
stronger.
In Fig. 2, for each data set, the differences between
the data set specific mean C index values obtained using
BlockForest and RSF and the differences between the data
set specific mean C index values obtained using Ran-
domBlock and RSF are shown. Both BlockForest and RSF
were better than RSF for 14 of the 20 data sets (70%),
where the degrees of these improvements differ quite
strongly across the data sets. Both variants outperformed
RSF by more than 0.05 in terms of absolute difference for
four of the data sets.
In Section C of Additional file 1 we analyze the influ-
ence of data set characteristics on the performance
of BlockForest relative to that of RSF. The improve-
ments of BlockForest over RSF tended to become greater
for larger sample sizes and slightly lower in cases in
which single blocks dominated the other blocks with
respect to their importances for prediction. Moreover,




Fig. 1Multi-omics data: Performances of the ten considered methods. aMean C index values for each of the 20 data sets and each of the ten
methods considered. b Differences between the mean C that obtained using RSF. c Data set specific ranks of each method among the other
methods in terms of the mean cross-validated C index values. The colored lines in a and b connect the results obtained for the same data sets
for weaker biological signals the degrees of improve-
ment attained through using BlockForest instead of
RSF varied more strongly, that is, for weaker signals
there were more often stronger improvements, but also
more often merely weak improvements and also (slight)
impairments.
We performed statistical testing to investigate whether
the improvements over RSF are statistically significant.
We performed a one-sided paired Student’s t-test for each
variant with the null hypothesis of non-inferiority of RSF
over the considered variant. In the tests, we treated the
data set specific mean C index values as independent
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Fig. 2Multi-omics data: Performances of BlockForest and RandomBlock relative to that of RSF. Differences between the mean C index values
obtained using BlockForest / RandomBlock and that obtained using RSF, ordered by difference between the values obtained for BlockForest and RSF
observations [23], which was possible because the dif-
ferent data sets feature different, non-overlapping sets of
samples. Because the tests therefore used one pair of mean
C index values per data set, each of them is based on
a sample size of 20. The five p-values for the variants
were adjusted for multiple testing with the Bonferroni-
Holm method. The following adjusted p-values were
obtained: 1.000 (VarProb), 1.000 (SplitWeights), 1.000
(BlockVarSel), 0.056 (RandomBlock), 0.027 (BlockForest).
Thus, BlockForest performed significantly better than
RSF, while RandomBlock showed merely a weakly signifi-
cant improvement over RSF (adjusted p-value larger than
0.05, but smaller than 0.10). The same conclusions were
obtained for the tests when excluding the three data sets
for which the measurements of only four of the five blocks
were available (results not shown).
In Section D of Additional file 1 we provide in-depth
analyses of the optimized values of the tuning parame-
ters associated with the different variants for each data
set. In the following we will merely present some impor-
tant conclusions obtained in these analyses, for details see
Additional file 1. The optimized block selection proba-
bilities b1, . . . , bM associated with RandomBlock can give
indications of the relative importances of the different
blocks for prediction, see “Methods” section.We obtained
the followingmean block selection probabilities across the
data sets (sorted from highest to lowest): 0.43 (mutation),
0.29 (RNA), 0.12 (clinical), 0.11 (CNV), 0.07 (miRNA).
Thus, the mutation block and the RNA block seem to be
by far the most important blocks. Moreover, we found
the correlations between the bm values (averaged per data
set) obtained for the mutation block and that obtained
for the RNA block to be strongly negative. This suggests
that there is a strong overlap in the information contained
in these two blocks. The correlation between the bm val-
ues of the clinical block and that of the mutation block
was negative, but that between the bm values of the clin-
ical block and that of the RNA block was very weak and
positive. This suggests that the additional predictive value
of the mutation block to the clinical block might in gen-
eral be smaller than that of the RNA block to the clinical
block. A strong additional predictive value of the RNA
block over the clinical block would make it particularly
effective to exploit the predictive information contained
in clinical covariates in situations in which such variables
are available in addition to RNA measurements.
We excluded the data set PRAD a posteriori from the
results. The survival times in this data set were censored
for more than 98% of the patients, leaving merely seven
observed events as opposed to 418 censored events. This
resulted in extremely unstable performance estimates,
since the C index cannot compare pairs of observations
for which the shorter time is censored. Note, however,
that it is a very delicate issue to exclude a data set from
a study after having observed the results for this data
set. Doing so offers potential for mechanisms related to
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fishing for significance [23, 24]. We obtained the follow-
ing mean cross-validated C index values for the data set
PRAD (sorted from largest to smallest): 0.584 (RSF) 0.545
(BlockVarSel) 0.522 (BlockForest) 0.504 (SplitWeights)
0.502 (RandomBlock) 0.500 (Boost) 0.467 (VarProb) 0.39
(priority-Lasso) 0.377 (IPF-LASSO). Lasso is not listed in
the mean C index values for this data set because all 25
iterations of the five times repeated 5-fold cross-validation
terminated with an error message. Also, in the cases of
boosting, IPF-LASSO, and priority-Lasso, there were iter-
ations that resulted in errors for this data set. Note that
the variant BlockForest that performed best overall, per-
formed worst in comparison to RSF for this data set
among all data sets. We suppose this bad result obtained
with BlockForest to be related to overfitting with respect
to the optimized tuning parameter values. While Ran-
dom Forest is quite robust with respect to the choice of
mtry [25], this is likely not the case for the variants with
respect to their block-specific tuning parameter values. As
described above, the C index values obtained for this data
set are very variable due to the small number of observed
survival times, which is why the optimized tuning param-
eter values can be expected to be very unreliable for this
data set. Therefore, the optimized tuning parameter val-
ues may be far from the values that are actually optimal for
these parameters, which could explain the bad prediction
performance.
Clinical covariates plus RNAmeasurements
Figure 3 shows the results obtained for the analysis in
which we used only the clinical block and the RNA block.
The results are presented in the same form as in Fig. 1.
Again, BlockForest performed best, achieving the highest
average C index value and a median rank of two.
Figure 4 shows the differences between the data set
specific mean C index values obtained using BlockForest
and RSF and the differences between the data set specific
mean C index values obtained using VarProb and RSF.
Note that here we show the results obtained for VarProb,
as opposed to those obtained with RandomBlock as in
Fig. 2, because here VarProb was the second best perform-
ing method in terms of the mean ranks of the methods
(see further down). BlockForest performed better than
RSF for 17 of the 20 data sets (85%), where for five of these
data sets the improvement of BlockForest over RSF was
greater than 0.05 in terms of absolute difference, while
there was only a mild improvement for other data sets.
VarProb showed an improvement over RSF for 14 of the 20
data sets (70%). The distributions of the ranks of themeth-
ods (Fig. 3c) reveal that BlockForest sets itself apart more
strongly from RandomBlock than in the analysis of the
multi-omics data. Moreover, excluding SplitWeights, now
also the other variants outperform RSF. The performance
of SplitWeights is very similar to that of RSF (Fig. 3b)
for the great majority of data sets. The reason for this
is probably that with SplitWeights as with RSF the clini-
cal covariates are selected very infrequently, which is why
the obtained predictions do not differ strongly between
these two methods if there is only a clinical block plus a
single omics block. As in the multi-omics case, the ranks
of IPF-LASSO are very variable, where this method now
performs worse than the variants and RSF. However, in
contrast to the multi-omics case, priority-Lasso outper-
forms IPF-LASSO here, but performs worse than most
of the variants. Regarding the methods that do not take
the block structure into account, again RSF takes the first
place, boosting the second place and Lasso the third place,
where the latter performs the worst out of all methods
here.We obtain the following mean ranks for the methods
(from best to worst): 2.65 (BlockForest), 4.10 (VarProb),
4.35 (RandomBlock), 4.70 (BlockVarSel), 5.40 (priority-
Lasso), 6.05 (RSF), 6.20 (SplitWeights), 6.65 (IPF-LASSO),
6.75 (Boost), 8.15 (Lasso). As already indicated above,
VarProb worked much better here than for the multi-
omics data. However, since BlockForest still performed
considerably better than VarProb, the latter cannot be rec-
ommended for the case of having a clinical block plus
an omics block available (nor for the multi-omics case).
An explanation for why VarProb performed better here
than in the multi-omics case, could be that the opti-
mized variable selection probabilities for the clinical block
were considerably larger than in the multi-omics case (see
Additional file 1: Figures S5 and S6 and Additional file
1: Figures S18 and S19, respectively). As will be seen in
“Outlook: Prioritizing the clinical covariates by includ-
ing them mandatorily in the split point selection” section,
artificially prioritizing the clinical block can improve the
prediction performance of the variants. The fact that the
optimized variable selection probabilities for the clinical
block are larger here can probably be explained by the
fact that the larger the number of blocks, the smaller the
optimized variable selection probabilities of the individ-
ual blocks will be, since the variable selection probabilities
add up to one. The C index values obtained for the individ-
ual repetitions of the cross-validation separately for each
data set are shown in Additional file 1: Figures S15 and
S16.
In the same manner as for the multi-omics data, we
performed t-tests to test for superiority of each of the vari-
ants over RSF, again adjusting for multiple testing using
Bonferroni-Holm. We obtained the following adjusted
p-values: 0.019 (VarProb), 0.238 (SplitWeights), 0.026
(BlockVarSel), 0.019 (RandomBlock), 0.01 (BlockForest).
Thus, there is a significant improvement over RSF for all
of the variants except for SplitWeights.
As for the analysis of the multi-omics data, we inves-
tigated the influences of different data set characteristics
on the performance of BlockForest relative to that of RSF.




Fig. 3 Clinical covariates plus RNA measurements: Performances of the ten considered methods. aMean C index values for each of the 20 data sets
and each of the ten methods considered. b Differences between the mean C index values obtained using the different methods and that obtained
using RSF. c Data set specific ranks of each method among the other methods in terms of the mean cross-validated C index values. The colored lines
in a and b connect the results obtained for the same data sets
There was no clear relation between the sample sizes and
the improvements of BlockForest over RSF, which could
be related to the fact that when considering only two
blocks instead of five (or four), less tuning parameter val-
ues have to be optimized. Moreover, the larger the bm
value of the clinical block optimized using RandomBlock
was, the greater the improvement of BlockForest over RSF
tended to be. This suggests that BlockForest performs par-
ticularly strong in situations in which there are highly
predictive clinical covariates. Lastly, the improvements of
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Fig. 4 Clinical covariates plus RNA measurements: Performances of BlockForest and VarProb relative to that of RSF. Differences between the mean C
index values obtained using BlockForest / VarProb and that obtained using RSF, ordered by difference between the values obtained for BlockForest
and RSF
BlockForest over RSF tended to be greater for weaker
biological signals. See Section F of Additional file 1 for
details.
Analogous to the multi-omics data case, in Section G of
Additional file 1 we provide detailed analyses of the opti-
mized tuning parameter values associated with the vari-
ants for each data set. Themean optimized block selection
probabilities associated with RandomBlock across data
sets were as follows: 0.24 (clinical), 0.76 (RNA). In the
median, the block selection probability of the RNA block
was 3.7 higher than that of the clinical block. This can
be interpreted as that the RNA block was in the median
3.7 times as important for prediction as the clinical block
for this collection of data sets when considering only the
clinical block and the RNA block. For further details, see
Additional file 1.
Above we made the presumption that the additional
predictive value of the mutation block to the clinical block
might be smaller than that of the RNA block to the clin-
ical block. In order to investigate whether the prediction
performance is actually lower when using the mutation
block instead of the RNAblock, we re-performed the anal-
ysis presented in this subsection using the clinical block in
combination with the mutation block, instead of in com-
bination with the RNA block. For each of the ten included
methods, the mean data set specific C index values were
smaller than in the case of using the RNA block, where
this was statistically significant for four of the tenmethods
after adjustment for multiple testing. Only the Block-
Forest variant significantly outperformed RSF (adjusted
p-value: 0.003). BlockForest and IPF-LASSO performed
best out of all methods here, where BlockForest featured
the lowest mean rank. See Section H of Additional file 1
for more details.
Outlook: Prioritizing the clinical covariates by including
themmandatorily in the split point selection
As noted above and also seen in the results of the analyses
presented in this paper, the clinical covariates often carry
much predictive information. In such cases, it might be
worthwhile artificially prioritizing these covariates in an
effort to improve the predictions.
For this reason, for each of the five random forest vari-
ants for multi-omics data presented in this paper, we
considered a variation that, for each split, includes all clin-
ical covariates in the sets of variables tried out for finding
the optimal split point. Apart from the latter the varia-
tions hardly differ from the original variants; see Section I
of Additional file 1 for detailed descriptions of these vari-
ations. We extended each of the three settings of the
comparison study considered in this paper (i.e., the multi-
omics case and the two cases using clinical covariates plus
RNA / mutation measurements) by the inclusion of these
variations.
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In Section J of Additional file 1 we show the results
of this analysis and discuss them in detail. In almost
all cases the variants benefited from including the clin-
ical covariates mandatorily. In the multi-omics case the
best performing method out of the now 15 methods was
the variation of RandomBlock that includes the clinical
covariates mandatorily, where the corresponding varia-
tion of BlockForest performed second best. In the two
cases that include the clinical block plus the RNA block
or the mutation block, respectively, the variation of Block-
Forest performed best overall, where in the case of using
the mutation block, the improvement over the original
BlockForest variant was very limited.
Even though in our comparison study considering the
clinical covariates mandatorily in the split point selection
improved the predictions in most cases, we do not rec-
ommend this strategy as a default choice. This is because,
whether or not we can expect improvements by including
the clinical covariates mandatorily, depends crucially on
the level of predictive information contained in the clin-
ical covariates. In situations in which the clinical covari-
ates contain less predictive information than those in the
data sets considered in the comparison study, artificially
prioritizing the clinical covariates might lead to worse
prediction results.
Discussion
The information overlap between the blocks that mani-
fests itself in negative correlations between the bm val-
ues (associated with RandomBlock) obtained for different
blocks, might help to explain why the two methods, block
forest aka BlockForest and RandomBlock performed best
in our comparison study. With both of these methods
the block choice is randomized for each split. Breiman
shows in the original random forest paper [19] that the
prediction performance of random forests benefits both
from strongly differing predictions of the individual trees
and from a strong prediction performance of the indi-
vidual tree predictors. For both BlockForest and Ran-
domBlock, the trees can be expected to differ to a stronger
degree than those obtained with the other variants. This is
because the succession of the blocks used for splitting in
the trees is random in the case of these twomethods, com-
pletely random for RandomBlock and partly random for
BlockForest. The fact that the trees differ more strongly
when randomizing the block choice leads tomore strongly
differing predictions of the individual trees. Moreover, the
fact that, by randomizing the block choice, not all blocks
are considered in each individual split can be expected
to have only a limited negative effect on the prediction
performance of the individual trees. The latter is due
to the fact that the predictive information contained in
the different blocks overlaps. To conclude, randomizing
the block choice should make the tree predictions more
different and strong at the same time, leading to a strong
prediction performance of the forest, as shown in [19].
The fact that four of the five variants delivered better
results than RSF for the case of using clinical covariates
plus RNAmeasurements indicates that it is crucial to treat
the clinical covariates differently than the omics variables.
As already mentioned in “Background” section, clinical
covariates often have high prognostic relevance. Due to
their small number in comparison to the omics variables,
these variables are too infrequently used for splitting in
a standard random (survival) forest, which is why their
prognostic value is not exploited in it. Of course, the latter
is also true for any other prediction method for high-
dimensional variable data applied to clinical covariates
plus a certain type of omics variables that does not differ-
entiate between clinical and omics variables. By extending
the comparison study by variations of the variants that
include the clinical covariates mandatorily, we saw that
it can even be effective to artificially prioritize the clin-
ical covariates. Even though we cannot recommend this
strategy as a default choice (see the previous subsection
for details), it should in each case be tried out in order
to assess, whether it can improve the prediction results
in the specific application. When including the clinical
covariates mandatorily, for multi-omics data (as opposed
to clinical covariates in combination with a single omics
data type), RandomBlock may be preferable over Block-
Forest. A problem with the base version of RandomBlock
that includes the clinical block in the collection of blocks
to sample from might be that the clinical covariates are
not considered frequently enough, because only a single
block is randomly drawn for each split. Note that when
trying out several approaches and choosing the one with
the optimal cross-validated prediction performance esti-
mate, this estimate is optimistically biased [26, 27]. A
simple solution to this issue would be to report, as a
conservative performance estimate, the worst prediction
performance estimate out of those obtained. Alternatively,
nested cross-validation can be used, that is, repeating the
model selection within an outer cross-validation loop. For
more sophisticated approaches, see [26].
While it can be very effective to allow for prioritization
of the clinical block over high-dimensional omics blocks,
less benefit can be expected from imposing different pri-
oritizations between omics blocks of similar size. This is
because, if the variables from two omics blocks of simi-
lar size are assigned the same prioritizations, the variables
from the more informative block will still be used more
often for splitting than the variables from the less infor-
mative block. These considerations also affect the inter-
pretation of the results obtained for the analysis of the
multi-omics data. As described in “Methods” section, in
the analysis of the multi-omics data, for blocks with more
than 2500 variables, we pre-selected the 2500 variables
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with smallest p-values from univariate Cox regressions. By
doing so, three of the four omics blocks had 2500 vari-
ables after pre-selection. The only block with less than
2500 variables was themiRNA block, which was, however,
non-informative for almost all data sets. Thus, all influ-
ential omics blocks had the same numbers of variables
(after pre-selection) in the analysis of the multi-omics
data. For this reason, the different prioritizations of the
omics blocks might not have been that crucial compared
to situations in which the informative omics blocks fea-
ture highly differing numbers of variables. In such situa-
tions, the expected performance gain by using BlockForest
instead of standard RSF might be larger. For example,
consider a scenario involving two blocks A and B, where
block A features 50 variables and block B 10000 vari-
ables. Suppose, moreover, that block A is informative and
block B is uninformative. In this situation, it is quite pos-
sible that RSF uses block B erroneously more often than
block A simply because block B contains more variables.
This is because, since observed data is subject to ran-
dom fluctuations, when continually searching for suitable
splits in uninformative variables, eventually a split will be
found that divides the observations well with respect to
the target variable. However, since the selected variable is
uninformative, the corresponding split will not be useful
when used in prediction, that is, applied to observations
external to the training data.
Comparing the mean C index values obtained when
using all available blocks (Fig. 1) and when using clinical
covariates plus RNA measurements (Fig. 3) an interest-
ing observation can be made: The mean C index values
are in most cases higher when using clinical covariates
plus RNA measurements only than when using all avail-
able blocks. This is true for both standard RSF as well
as for the variants. When using all available blocks there
is more predictive information available than when using
only a single block, which is why it appears contradic-
tory at first that the prediction performance is worse when
considering all available blocks for prediction. However,
we can make three observations that help to explain, why
the prediction rules obtained using the combination of the
clinical block and the RNA block performed that strongly.
First, the results obtained in Section D of Additional file
1 suggested that the predictive information contained in
the two most important blocks, the mutation block and
the RNA block, is highly overlapping. The evidence that
supported this assumption was that the method Ran-
domBlock in the great majority of cases attributed a very
large value of the selection probability to one of these two
blocks and a very small value to the respective other block.
The strong overlap in information between the mutation
block and the RNA block has the effect that there tends
to be limited gain in prediction accuracy by including the
mutation block in addition to the RNA block even though
the mutation block does contain much predictive infor-
mation. Second, the RandomBlock algorithm attributed in
most cases small selection probabilities to the remaining
blocks, which suggests that thesemost often provided lim-
ited additional predictive value over the mutation block
and/or the RNA block. Third, the results obtained with all
blocks also suggested that the additional predictive value
of the RNA block over the clinical block is higher than
that of the mutation block over the clinical block. The
prediction performances of the methods were also bet-
ter when using the clinical block in combination with the
RNA block then they were when using the clinical block in
combination with the mutation block (significantly better
for four of the ten methods). For these three reasons, in
practice it should in many cases be sufficient to consider
only the clinical information plus the RNAmeasurements.
Such prediction rules are quite convenient to handle. This
is because it is merely required that the necessary clini-
cal information and the RNA measurements are available
instead of measurements of a multitude of different omics
data types, both, for the purpose of constructing the pre-
diction rule and, even more importantly, for the purpose
of applying it.
Because the variants feature a tuning parameter for each
block, the numbers of involved tuning parameters are rel-
atively large. As discussed already in “Results” section
in the context of describing the results obtained for the
data set PRAD, this might be associated with an overfit-
ting mechanism: the optimized tuning parameter values
might be overly well adjusted to the given data set. The
fact that we observed a trend of greater improvements of
BlockForest over RSF for larger data sets is indicative of
that. Nevertheless, as the results of the comparison study
demonstrate, this overoptimism, in case it exists, is weak
enough to warrant that BlockForest still outperforms RSF
(to varying degrees) for the majority of data sets.
For each of the variants, we fixed the number of vari-
ables to be randomly sampled at each split. The reason
for this choice was to avoid the need of having to opti-
mize another tuning parameter. Nevertheless, it might be
worthwhile to consider optimizing this number or rather
the proportion of variables from all variables to be sam-
pled (where in the cases of BlockVarSel, RandomBlock,
and BlockForest sampling from each block is performed).
By contrast, in the case of RSF we did optimize the num-
ber mtry of variables sampled for each split, which likely
explains, why some of the variants performed even worse
than RSF in the comparison study.
As noted in “Background” section, the considered vari-
ants are applicable for any types of outcomes (e.g., categor-
ical or continuous outcomes), for which there exists a ran-
dom forest variant. Our comparison studies were limited
to survival outcomes. However, the discussed advantage
of block forest (and RandomBlock), that it tackles the issue
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of overlapping predictive information between the blocks
holds also for other types of outcomes. Nevertheless, to
assess the prediction performance of block forest for other
types of outcomes, analogous comparison studies like the
one performed in this paper would be necessary.
Conclusions
Using a collection of 20 real multi-omics data sets we com-
pared the prediction performance of five different can-
didate random (survival) forest variants for multi-omics
covariate data to that of competitors, in particular to that
of random survival forest, which we considered as a refer-
ence method. We also considered the common situation
of having only the clinical block plus a single type of
omics data (in our case RNA or mutation measurements,
respectively) available. Both, for the latter case and for
the multi-omics data the variant “BlockForest” or “block
forest” performed best and significantly better than the
reference method random survival forest. Therefore, we
recommend using block forest in applications to exploit
effectively the predictive information contained in combi-
nations of clinical data and one or several types of omics
data. The other random forest variants can be consulted
for academic purposes, for example, in the context of
further methodological developments. Depending on the
level of information contained in the clinical covariates,
considering these covariates mandatorily in the split point




A multi-omics data set with n observations consists of
M covariate matrices X1, . . . ,XM and an outcome vec-
tor y1, . . . , yn. The mth matrix Xm of dimension n × pm
contains, for each observation, the measurements of the
pm variables in the mth block. The outcome values yi,
i = 1, . . . , n, are most often scalars, for example yi ∈ {0, 1}
for binary outcomes or yi ∈ R for metric outcomes. They
may, however, also take the form of vectors, for example
yi = {yi,1, yi,2} with yi,1 ∈ R>0 and yi,2 ∈ {0, 1} for survival
outcomes, where yi,1 denotes the survival/censoring time
of the ith observation and yi,2 its value of the censoring
indicator. The covariate matrices can be concatenated in
order to form a single covariate matrix X :=[X1, . . . ,XM]
with p = ∑Mm=1 pm columns.
Split selection procedures for random forests tailored to
multi-omics data
As described in “Background” section, the five consid-
ered random forest variants for multi-omics data differ
merely with respect to split point selection. In the follow-
ing, we first recall the standard random forest algorithm
and the split point selection performed by this algorithm.
Subsequently, we describe the split point selection pro-
cedures of the considered variants and briefly discuss
the motivations behind each of these approaches. Each
of these procedures involves block-specific parameters,
which are chosen automatically using an optimization pro-
cedure described in “Optimization of tuning parameters”
section.
Standard random forest
A random forest prediction rule is a collection of decision
trees, where each of the latter is constructed using a sub-
sample or bootstrap sample of a training data set. Each of
the tree decision rules performs a series of binary deci-
sions, where each decision is obtained using a threshold,
called “split point”, in the values of one of the covariate
variables available in the training data set. The decision
trees are constructed by recursively dividing the available
samples in two subgroups using the split points which are
obtained during the construction of the trees. The nested
subgroups are denoted as nodes.
In standard random forest a split point for a node in
a tree is obtained as follows (assuming only continuous
variables for ease of presentation). First, a numbermtry of
variables is randomly sampled from all variables. Second,
an optimal split point in the ordered values of the sam-
pled variables is obtained in the following way: 1) Divide
the node once according to each possible split point in
each variable and for every division obtained, calculate
the value of a certain quantitative split criterion; 2) Use
that split point among all split points considered in 1)
that was best according to the split point criterion. The
block structure of multi-omics data is obviously not taken
into account in this split point selection procedure. Note
that the split point selection is performed slightly differ-
ently for nominal variables, for details see Hastie et al. [28]
(chapter 9.2.4).
VarProb: Block-specific variable selection probabilities
The procedure of drawing from all variables without tak-
ing the block structure into account, as performed in
the split point selection of standard random forest, has
two main issues. First, with this procedure, blocks that
involve fewer variables are underrepresented in the drawn
variables. In many cases, it would be preferable if a vari-
able from a block with fewer variables would be drawn
more often than a variable from a block with many vari-
ables. This is because the predictive information in blocks
with fewer variables is often more dense. For example,
it is well known that, while the block containing clinical
information does usually contain a very small number of
variables in comparison to the omics blocks, a large frac-
tion of this small number of variables can be expected to
be highly predictive. Beyond this specific example, there
needs to be a negative correlation between block size
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and information density. If, by contrast, this was not the
case, this would either mean that the amount of predic-
tive information of a block has a positive dependency on
its size, or that informative variables are weaker in larger
blocks.
The second, related issue is that even for equal block
sizes, the procedure of drawing variables from differ-
ent blocks with the same frequencies does not take into
account that the blocks differ with respect to their lev-
els of predictive information contained. It could be an
advantage if variables from blocks with much predictive
information would be drawn more often than variables
from blocks with little predictive information.
Both of the above issues are addressed by using block-
specific variable selection probabilities in the variant
VarProb presented in this subsection. This has the effect
that the sampling probabilities of variables from some
blocks are higher than those of variables from other
blocks. With the split selection procedure of VarProb,
a variable in block m has sampling probability vm,
where we ensure that the sampling probabilities of all
variables add up to one, that is, we impose the fol-
lowing restriction:
∑M
m=1 pmvm = 1. Note that the
v1, . . . , vM are the block-specific parameters of VarProb,
which are, as noted above, optimized automatically (see
“Optimization of tuning parameters” section). In order
to fix the number of variables to be drawn for each split
to mtry we proceed as follows: Each sampled variable is
drawn one after another. If, in this process, a variable is
drawn that is already in the set of drawn variables, the
drawing is repeated until a variable is drawn that is not
yet in the set of drawn variables. This process is repeated
until mtry variables have been drawn. Finally, the best
split point is determined in the mtry drawn variables as
in standard random forest. The value of mtry is set to∑M
m=1
√pm.
SplitWeights: Block-specific weights of split criterion values
Using block-specific variable selection probabilities in
VarProb has the effect of prioritizing some blocks over
others. Another way to accomplish the latter is to
use block-specific weights wm (m = 1, . . . ,M) for
the split criterion values, where w1, . . . ,wm > 0 and
max{w1, . . . ,wM} = 1 for reasons of identifiability. With
this procedure, variables from blocks with high wm val-
ues are prioritized over variables from blocks with low
wm values. First, a number of mtry = ∑Mm=1 √pm
variables are drawn from all variables, as in conven-
tional random forest. Second, the split criterion values
associated with all split points in the sampled variables
are calculated and these values are weighted using the
block-specific weights wm. Third, the split point is cho-
sen that features the highest weighted split criterion
value.
As in the case of VarProb, with SplitWeights variables
from different blocks are prioritized differently by the pro-
cedure. Because the predictive information contained in
blocks with large numbers of variables tends to be less
dense, more variables need to be sampled from these
blocks in order to increase the likelihood of obtaining rea-
sonably informative variables. However, when sampling
different numbers of variables from different blocks in this
way, the best variable from a large block tends to sepa-
rate the observations better than the best variable from a
small block just by chance, even though the best variable
from the small block is often actually more suitable. This
problem occurs for the same reason as the bias towards
variables with many possible split points described by
Strobl et al. [29]. The tendency of selecting suboptimal
variables from large blocks is avoided when the split
criterion values of these blocks are attributed smaller
weights wm.
BlockVarSel: Separate sampling of variables from each block
and block-specific weights of split criterion values
A disadvantage of SplitWeights is that the smaller the
number of variables in a block is, the smaller is the prob-
ability that this block is present in the variables sampled
for a split. For example, a block containing clinical infor-
mation most often contains only few variables, which is
why there will be no clinical covariates among the sam-
pled variables for most of the splits. Clinical covariates,
however, often contain much predictive information and
interact with omics variables, which is why it is detrimen-
tal if they are considered only infrequently.
In order to avoid the above shortcoming of
SplitWeights, with the split selection procedure Block-
VarSel presented in this subsection, for each split, we
sample fixed numbers of variables from each block sepa-
rately. More precisely, for m = 1, . . . ,M we sample √pm
variables from blockm. Subsequently, split point selection
is performed as with SplitWeights, that is, using weighted
split criterion values with block-specific weights wm.
Note that with this approach, as with SplitWeights, larger
numbers of variables are sampled from larger blocks.
RandomBlock: Randomblock selection
A key reason for the strong prediction performance of
standard random forest is that through considering only a
random subset of mtry variables for each split, the result-
ing trees are very dissimilar from each other. Roughly
formulated, each tree captures different aspects of the
complex dependency structure between the outcome and
the variables. In the context of multi-omics data, we are
particularly interested in rendering aspects of the inter-
play of the different blocks with respect to their influence
on the outcome. Therefore, it seems beneficial tomake the
trees not only very dissimilar with respect to the involved
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variables in general, but also in particular with respect to
the involvements of the different blocks.
On the basis of this idea, with the split selection pro-
cedure RandomBlock, first, one of the blocks is selected
randomly and, second, a subset of variables from the
selected block is sampled. The sampled subset of vari-
ables from the selected block is subsequently considered
for splitting and split point selection is performed among
the sampled subset of variables as in standard random
forest. In order to account for the different levels of pre-
dictive information associated with the different blocks,
block-specific selection probabilities bm are used, where∑M
m=1 bm = 1. After block selection, √pm variables are
sampled from the selected block.
The fact that the succession of the blocks used for split-
ting is random within the trees makes the resulting forest
put high emphasis on rendering interactions between
variables across blocks. A further distinctive property of
this split selection procedure is that there are no com-
parisons of split points made across blocks, since only
variables from a single block are considered for each
split. This avoids issues with differences in dimensionality
between the blocks that have to be dealt with in the other
approaches. Moreover, it avoids problems caused by cor-
relations between variables from different blocks, where
these correlations are associated with the fact that the pre-
dictive information contained in different blocks is over-
lapping. A further advantage of RandomBlock is that the
bm values can give indications of the relative importances
of the different blocks for prediction. The higher the bm
value of a block is, the higher its importance compared to
the other blocks will tend to be. However, small bm values
must be interpreted with great care,because important
blocks can be attributed small bm values if these blocks
share much predictive information with other important
blocks. For details on this mechanism see Section D of
Additional file 1 referenced in “Multi-omics data” subsec-
tion of “Results” section. The bm values may also be used
to screen out blocks that are not relevant for prediction
given the remaining blocks. This can be done by excluding
blocks that feature very small bm values.
BlockForest: Block sampling with separate sampling of
variables from each block and block-specific weights of split
criterion values
A major advantage of the procedure RandomBlock that
is described in the previous subsection is that it adds the
additional randomization component “block selection” to
the standard random forest algorithm. For the procedure
described in the current subsection we extended the pro-
cedure BlockVarSel by a block selection randomization
procedure. The new procedure is performed as follows: 1)
Obtain a subset of all M blocks by selecting each block
with probability 0.5, that is, all blocks are selected with
probability 0.5M and no block at all with the same prob-
ability; 2) If no block was selected, repeat 1) until at least
one block is selected; 3) Perform the split selection pro-
cedure of BlockVarSel using only the blocks selected in
1) or 2), respectively. This new procedure leads to more
strongly differing trees than BlockVarSel, because weaker
blocks are better taken into account. We use the general
term “BlockForest” or “block forest” for this procedure,
because it performed best among the studied procedures
in our comparison study.
Optimization of tuning parameters
Each of the split point selection procedures described
above contains M tuning parameters, where each tun-
ing parameter is associated with one of the blocks.
These tuning parameters are variable selection proba-
bilities v1, . . . , vM for VarProb, block weights w1, . . . ,wM
for SplitWeights, BlockVarSel and BlockForest, as well as
block selection probabilities b1, . . . , bM for RandomBlock.
The optimization of the tuning parameter values is
performed as follows for each of the five variants:
1 For it = 1, . . . ,Nsets:
(a) Generate a random set S it of M tuning
parameter values.
(b) Construct a forest with num.treespre trees
using the tuning parameter value set S it and
record the out-of-bag prediction error of that
forest.
1 Use that tuning parameter set out of S1, . . . ,SNsets ,
for which the corresponding forest delivered the
smallest out-of-bag prediction error.
The generation of the random sets of tuning parameter
values is described in Section K of Additional file 1. The
choice of the prediction error measure depends on the
considered outcome. For survival data (see the compari-
son study presented in “Comparison study” section), we
use one minus the value of Harrell’s C index.
Note that while the optimization algorithm presented
above is relatively inefficient, it has the important advan-
tage that it is consistent with respect to the tuning
parameter value set actually associated with the lowest
out-of-bag prediction error. That is, for larger values of
Nsets, the optimized tuning parameter set will approx-
imate the optimal tuning parameter value set, that is,
the set with lowest possible out-of-bag prediction error,
increasingly well. By contrast, the properties of more
sophisticated procedures tend to be less clear, which is
why such procedures can be prone to result in local
optima. In our analyses, we use the valuesNsets = 300 and
num.treespre = 1500, which are also the default values in
our R package blockForest. Such large numbers of sets
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and trees per constructed forest are possible because the
package blockForest is a fork of ranger [30], which
is a fast C++ random forest implementation.
Comparison study
Data
We used 21 real multi-omics data sets with survival
outcome, where each of these data sets contains mea-
surements of patients with a certain cancer type. All
data sets were downloaded from the database The Can-
cer Genome Atlas Project (TCGA) [31]. As described
in “Results” section the data set ‘PRAD’ (cf. Table 1)
was excluded a posteriori for reasons unrelated to the
results obtained with this data set. The following blocks
were present among the data sets: clinical information,
miRNA data, mutation data, copy number variation mea-
surements, and RNA data. Not every block was available
for each data set: For two data sets (‘CESC’ and ‘GBM’)
the miRNA block was not available and for one data set
(‘READ’) there was no mutation data. While the num-
bers of variables available for each block do differ between
the data sets, they are all in the same order of magnitude
across data sets. On average, the following numbers of
variables were available for each block: 4.5 (clinical block),
780.3 (miRNA block), 16579.8 (mutation block), 57888.4
(CNV block), 23442.6 (RNA block). Table 1 provides an
overview of the data sets. In Additional file 1: Table S1
we provide a more detailed overview of the data sets in
which we provide the numbers of variables available for
each block in each data set.
We used k nearest neighbors imputation to impute
missing values in the clinical block in data sets with
more than two clinical covariates. We used the function
knnImputation from the R packageDMwR [32]. In cases
with only two variables this was not possible because
knnImputation is only applicable for a minimum of
three variables. Here, we used univariate logistic regres-
sion for imputation. Note that by performing the impu-
tation before the cross-validation used for performance
estimation, we performed incomplete cross-validation,
which, depending on the analysis step performed out-
side of the cross-validation, can lead to overoptimism in
the resulting prediction performance estimates [33]. How-
ever, performing incomplete cross-validation with respect
to imputation has been found to not affect the perfor-
mance estimates to any relevant degree [33].
Study design
We compared the five variants VarProb, SplitWeights,
BlockVarSel, RandomBlock, and BlockForest to RSF as
a reference method and to four further methods: two
prediction methods for high-dimensional covariate data,
model-based gradient boosting [34] and CoxLasso [35],
and two prediction methods for multi-omics covariate
Table 1 Overview of the data sets used in the comparison study





BRCA Breast Invasive Carcinoma 863 9%





COAD Colon Adenocarcinoma 350 22%
ESCA Esophageal Carcinoma 121 21%
GBM Glioblastoma Multiforme 154 73%
HNSC Head and Neck Squamous
Cell Carcinoma
411 35%
KIRC Kidney Renal Clear Cell
Carcinoma
322 22%
KIRP Kidney Renal Papillary Cell
Carcinoma
249 10%




LUAD Lung Adenocarcinoma 424 30%









PRAD Prostate Adenocarcinoma 425 2%
READ Rectum Adenocarcinoma 138 16%
SARC Sarcoma 183 16%
SKCM Skin Cutaneous Melanoma 264 25%




The following information is given: Name of the data set, cancer type, sample size
and the percentage of observations for which the survival time was uncensored.
Note that the TCGA Project ID of each data set is “TCGA-[Name]”, with “[Name]”
being the name of the data set (given in the first column)
data, IPF-LASSO and priority-Lasso. Note again that
since the data sets considered in the comparison study
are survival data sets, the latter five forest variants for
multi-omics data are variants of the RSF algorithm.
As noted in “Optimization of tuning parameters”
section we set Nsets = 300 and num.treespre = 1500 for
the forest variants. After optimizing the tuning parameter
value sets, we constructed forests with 2000 trees. For RSF
we optimized the values of mtry using grid search: First,
for each mtry ∈ {x√p|x ∈ {0.1, 0.25, 0.5, 1, 2}} we con-
structed an RSF with 1500 trees and, second, used that of
themtry values tried that was associated with the smallest
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out-of-bag prediction error. Subsequently, we constructed
a forest with 2000 trees as in the case of the variants.
The optimization of mtry was performed, because the
performance of random survival forest depends on the
value chosen for this parameter. As split criterion we used
the log-rank test statistic. Because of the computational
expense of log-rank tests, evaluating each possible split
point for each considered variable is too expensive in
the context of forests applied to high-dimensional data.
Therefore, for each variable tried, we merely considered
one randomly sampled split point. This split point selec-
tion procedure is known as extremely randomized trees
[36] for classification and regression trees. In an extensive
comparison study, extremely randomized trees have been
found to feature similar or even slightly better prediction
performance than conventional trees for which each split
point is tried out for each considered variable [36].
The numbermstop of boosting steps inmodel-based gra-
dient boosting and the shrinkage parameter λ of CoxLasso
were both optimized using cross-validation in each itera-
tion of the (outer) cross-validation used to estimate the C
index values (see further down). The IPF-LASSO features
a shrinkage parameter for each block. Unless the number
of blocks is low, using cross-validation to optimize these
shrinkage parameters becomes computationally challeng-
ing due to the large number of shrinkage parameter value
tuples needing to be considered in the optimization. As
a solution to this issue, the two-step IPF-LASSO [37]
was developed which we used in the comparison study.
In the first step of this approach, for each block a so-
called penalty factor is determined. In the second step,
a CoxLasso model is fitted to the data, optimizing the
shrinkage parameter using cross-validation, where in the
penalty term of the optimization problem, the parame-
ters are multiplied by the block-specific penalty factors.
The block-specific shrinkage parameters are subsequently
determined by multiplying the shrinkage parameter opti-
mized in the second step by the penalty parameters.
Roughly speaking, the penalty factors should be inverse
proportional to the importances of the blocks, that is, the
more important a block becomes, the smaller should be
its penalty factor. In the case of the priority-Lasso, we
did not have enough background knowledge to use sub-
stantial considerations for setting the priority orders of
the blocks for the different data sets. For this reason, we
chose the priority orders using the values of the penalty
factors determined in the first step of the two-step IPF-
LASSO: the block with the smallest penalty factor was
attributed the highest priority, the block with the second
smallest penalty factor the second highest priority and so
on. We used the default priority-Lasso version without
cross-validated offsets to reduce the computational bur-
den, even though the version with cross-validated offsets
delivers slightly better prediction results [11].
We used 5-fold cross-validation repeated five times to
measure the performance of each method on each data
set. As a performance metric we used Harrell’s C index for
which we used the short form C index above. First, we cal-
culated the C index on the left out fold in each iteration of
the repeated cross-validation and, second, took the aver-
age of these values across the iterations and repetitions
of the cross-validation. In the case of the data set PRAD
that was excluded from the analysis of the results (see
“Multi-omics data” section of “Results” section for
details), the application of some methods terminated
with errors for several cross-validation iterations. For
other data sets, this was the case only for the meth-
ods boosting and priority-Lasso. While the application of
priority-Lasso terminated prematurely for only few cross-
validation iterations, for boosting errors occurred more
frequently. In very rare cases the C index was not calcula-
ble on the left out fold for an iteration due to lack of com-
parable pairs of observations. All iterations with missing
results were left out when calculating the corresponding
averages.
In the case of blocks with more than 2500 variables, we
conducted supervised variable selection on the training
data sets within cross-validation, selecting the 2500 vari-
ables that featured the smallest p-values in univariate Cox
regression. This was performed both, for computational
efficiency and because for ultra high-dimensional omics
data types most variables can be assumed to be without
effect.
We performed the analysis once using all available
blocks for each data set (including the clinical block) and
once using only the clinical block and the RNA block.
As described in “Background” section, the latter setting
of having clinical covariates plus a certain type of omics
data available is frequently occurring in practice. For this
reason we were interested in comparing the methods also
with respect to their performance when applied in this set-
ting. We chose the RNA block as the involved omics block
in this analysis, because this omics data type seems to
be one of the most commonly found in practice, of those
available for the considered data sets.
Additional files
Additional file 1: Additional contents referenced in the paper. This file
contains all Supporting Information referenced in the paper: AMulti-omics
data: C index values obtained for the individual repetitions of the
cross-validation. BMulti-omics data: Results obtained for the 17 data sets,
for which all five blocks were available. CMulti-omics data: Analysis of the
influence of data set characteristics on the performance of BlockForest
relative to that of RSF. DMulti-omics data: Optimized block-specific tuning
parameter values associated with the different variants. E Clinical
covariates plus RNA measurements: C index values obtained for the
individual repetitions of the cross-validation. F Clinical covariates plus RNA
measurements: Analysis of the influence of data set characteristics on the
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performance of BlockForest relative to that of RSF. G Clinical covariates plus
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parameter value optimization. L Overview of the data sets used in the
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written to perform the analyses presented in this paper and in Additional
file 1 as well as Rda files enabling fast evaluation of the results. (ZIP 26,855 kb)
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